
Sheela Jitendra Huff
Examiner (ID: 13612, Phone: (571)272-0834 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1811, 1643, 1642, RD00, 1806 |
| Total Applications | 2210 |
| Issued Applications | 1470 |
| Pending Applications | 183 |
| Abandoned Applications | 574 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7515373
[patent_doc_number] => 08039445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Methods and devices for delivering a therapeutic product to the ocular sphere of a subject'
[patent_app_type] => utility
[patent_app_number] => 11/911771
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 29
[patent_no_of_words] => 20146
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911771
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911771 | Methods and devices for delivering a therapeutic product to the ocular sphere of a subject | Apr 17, 2006 | Issued |
Array
(
[id] => 5618955
[patent_doc_number] => 20060188488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Prevascularized constructs for implantation to provide blood perfusion'
[patent_app_type] => utility
[patent_app_number] => 11/406950
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13772
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188488.pdf
[firstpage_image] =>[orig_patent_app_number] => 11406950
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/406950 | Prevascularized constructs for implantation to provide blood perfusion | Apr 17, 2006 | Abandoned |
Array
(
[id] => 5642271
[patent_doc_number] => 20060280726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof'
[patent_app_type] => utility
[patent_app_number] => 11/403788
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16520
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20060280726.pdf
[firstpage_image] =>[orig_patent_app_number] => 11403788
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403788 | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof | Apr 11, 2006 | Issued |
Array
(
[id] => 5879620
[patent_doc_number] => 20060168666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Autoimmune disease model animal'
[patent_app_type] => utility
[patent_app_number] => 11/396873
[patent_app_country] => US
[patent_app_date] => 2006-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6528
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20060168666.pdf
[firstpage_image] =>[orig_patent_app_number] => 11396873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/396873 | Autoimmune disease model animal | Apr 2, 2006 | Issued |
Array
(
[id] => 5834657
[patent_doc_number] => 20060246488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Transcriptional profiling of stem cells and their multilineage differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/394766
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10791
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246488.pdf
[firstpage_image] =>[orig_patent_app_number] => 11394766
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/394766 | Transcriptional profiling of stem cells and their multilineage differentiation | Mar 30, 2006 | Issued |
Array
(
[id] => 5051314
[patent_doc_number] => 20070031859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same'
[patent_app_type] => utility
[patent_app_number] => 11/393820
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21476
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031859.pdf
[firstpage_image] =>[orig_patent_app_number] => 11393820
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/393820 | Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same | Mar 30, 2006 | Abandoned |
Array
(
[id] => 4784948
[patent_doc_number] => 20080138277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Delivery systems and methods for diagnosing and treating cardiovascular diseases'
[patent_app_type] => utility
[patent_app_number] => 11/386513
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12455
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138277.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386513 | Delivery systems and methods for diagnosing and treating cardiovascular diseases | Mar 22, 2006 | Abandoned |
Array
(
[id] => 23452
[patent_doc_number] => 07795027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Extracellular matrix composite materials, and manufacture and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/368077
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 27
[patent_no_of_words] => 13787
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795027.pdf
[firstpage_image] =>[orig_patent_app_number] => 11368077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/368077 | Extracellular matrix composite materials, and manufacture and use thereof | Mar 2, 2006 | Issued |
Array
(
[id] => 4813387
[patent_doc_number] => 20080194018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Isolated Myeloid-Like Bone Marrow Cell Populations and Methods of Treatment Therewith'
[patent_app_type] => utility
[patent_app_number] => 11/884958
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 24329
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884958 | Isolated myeloid-like bone marrow cell populations and methods of treatment therewith | Feb 23, 2006 | Issued |
Array
(
[id] => 5655187
[patent_doc_number] => 20060140922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Universal GM-CSF expressing bystander human K562 cell line'
[patent_app_type] => utility
[patent_app_number] => 11/361832
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7063
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140922.pdf
[firstpage_image] =>[orig_patent_app_number] => 11361832
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/361832 | Universal GM-CSF expressing bystander human K562 cell line | Feb 22, 2006 | Issued |
Array
(
[id] => 833239
[patent_doc_number] => 07396528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Corneal cells expressing active agents and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/343971
[patent_app_country] => US
[patent_app_date] => 2006-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10038
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396528.pdf
[firstpage_image] =>[orig_patent_app_number] => 11343971
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/343971 | Corneal cells expressing active agents and methods of use thereof | Jan 29, 2006 | Issued |
Array
(
[id] => 5706870
[patent_doc_number] => 20060195918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Embryonic stem cell self maintenance and renewal reporter'
[patent_app_type] => utility
[patent_app_number] => 11/332943
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 18618
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20060195918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11332943
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/332943 | Embryonic stem cell self maintenance and renewal reporter | Jan 16, 2006 | Issued |
Array
(
[id] => 5778697
[patent_doc_number] => 20060107337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Elimination of endogenous porcine retrovirus'
[patent_app_type] => utility
[patent_app_number] => 11/322999
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10157
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20060107337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11322999
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/322999 | Elimination of endogenous porcine retrovirus | Dec 29, 2005 | Abandoned |
Array
(
[id] => 5683510
[patent_doc_number] => 20060199780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Methods for modulating T cell survival by modulating bcl-XL protein level'
[patent_app_type] => utility
[patent_app_number] => 11/296725
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24241
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199780.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296725 | Methods for modulating T cell survival by modulating bcl-XL protein level | Dec 1, 2005 | Abandoned |
Array
(
[id] => 5912950
[patent_doc_number] => 20060128012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Substrate recognition by differentiable human mesenchymal stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/291701
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7344
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128012.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291701 | Substrate recognition by differentiable human mesenchymal stem cells | Nov 30, 2005 | Abandoned |
Array
(
[id] => 5693661
[patent_doc_number] => 20060153808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Cancer immunotherapy incorporating p53'
[patent_app_type] => utility
[patent_app_number] => 11/281922
[patent_app_country] => US
[patent_app_date] => 2005-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23371
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153808.pdf
[firstpage_image] =>[orig_patent_app_number] => 11281922
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/281922 | Cancer immunotherapy incorporating p53 | Nov 16, 2005 | Abandoned |
Array
(
[id] => 4824857
[patent_doc_number] => 20080124304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Method for the Generation of Virus Producing Cell Lines and Cell Lines'
[patent_app_type] => utility
[patent_app_number] => 11/718385
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9416
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124304.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718385
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718385 | Method for the Generation of Virus Producing Cell Lines and Cell Lines | Oct 31, 2005 | Abandoned |
Array
(
[id] => 4927393
[patent_doc_number] => 20080166756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited'
[patent_app_type] => utility
[patent_app_number] => 11/793649
[patent_app_country] => US
[patent_app_date] => 2005-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16937
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20080166756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793649
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793649 | Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited | Oct 25, 2005 | Abandoned |
Array
(
[id] => 5613970
[patent_doc_number] => 20060115898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Cultured hematopoietic stem cells and method for expansion and analysis thereof'
[patent_app_type] => utility
[patent_app_number] => 11/255191
[patent_app_country] => US
[patent_app_date] => 2005-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13029
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255191 | Cultured hematopoietic stem cells and method for expansion and analysis thereof | Oct 19, 2005 | Issued |
Array
(
[id] => 4458875
[patent_doc_number] => 07879321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production'
[patent_app_type] => utility
[patent_app_number] => 11/245835
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 14203
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879321.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245835 | Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production | Oct 6, 2005 | Issued |